Items of recent pandemic news: Boosters approved for kids 5-11; the cause of severe Covid-19; two new vaccines built on different technology bases; immune evasiveness of two Omicron sub-variants; Paxlovid developments; and much more. Plus a frippery. The pandemic sputters … Continue reading →
This newsletter is tapering down. For 25 months I have been documenting the medical and scientific history of this extraordinary time. The country now acts as if it is over; what urgency the pandemic still commanded is leaching out. Herewith … Continue reading →
Items of recent pandemic news: The criticality of public trust to public health; how history says the pandemic will end; two promising, broad-spectrum inhalable vaccines in development; and the state of the BA.2 Omicron sub-variant. Plus a frippery. Quote of … Continue reading →
Items of recent pandemic news: Omicron boosters prove unhelpful; wastewater surveillance comes into its own; Covid-19 causes long-term heart and circulatory issues; results from the first SARS-CoV-2 challenge trial published; and more. Plus two fripperies. Quote of the week Eric … Continue reading →
Items of recent pandemic news: Cryptic Covid lineages in NYC wastewater; a possible stall in Omicron’s nationwide decline; Novavax files for EUA and Moderna is approved; and authorized vaccines for the youngest kids, within a few weeks. Plus a frippery. … Continue reading →
Items of recent pandemic news: Historical perspective and promising research on long Covid; beginning Omicron-targeted vaccine trials; press attention for a new CBD study; Hong Kong’s zero-Covid strategy and Omicron; and BA.2 in the US. Plus a frippery. Quotes of … Continue reading →
Items of recent pandemic news: A resource for finding authorized therapeutics in the US; how long booster shots protect; an early study isolating ultrapotent antibodies from elite neutralizers; and a new variant on the Omicron variant. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Monitoring sewage for Covid early warning; therapeutics in short supply; a variant of little concern; antigen tests may miss early infectivity; Pfizer boost authorized for 12-15-year-olds; and more. Plus a frippery. Quote of the week … Continue reading →
Items of recent pandemic news: A new “vaccine for the world,” developed in Texas, is authorized in India; more evidence that Omicron is less severe; towards a broad-spectrum vaccine; the CDC’s controversial new guidelines; and more. Plus a frippery. Quote … Continue reading →
Items of recent pandemic news: Minnesota’s oddly bright prospects; Israel offers a fourth shot; the end of the pandemic as a social phenomenon; and what happens when Omicron hits a population with pre-existing immunity. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Novavax notches some wins; J&J’s vaccine is deprecated; vaccines for young kids will have to wait; the US government is stockpiling antibodies; the implications of Omicron’s (possibly) faster incubation; and more. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Those who pay zero attention to the pandemic; the evolutionary weirdness of Omicron; the class-based roots of vaccine avoidance; boosters authorized for people aged 16-17; and Paxlovid’s continuing promise. Plus a frippery. Paxlovid holds up … Continue reading →
Items of recent pandemic news: A common cold coronavirus may have mixed into Omicron; AstraZeneca’s long-lasting injectable antibody gets authorized; SARS-CoV-2 can infect fat cells; what we tentatively know about Omicron; and much more. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Simulating an aerosolized virus particle with 1.3 billion atoms via a supercomputer; the first monoclonal antibody treatment authorized for young children; Omicron may be breaking through natural immunity; and molnupiravir’s tepid affirmation. Plus a frippery. … Continue reading →
Items of recent pandemic news: Survivors of severe Covid have double the odds of dying, from all causes, within a year; Minnesota’s fading Delta surge; where the Omicron variant may have come from; and more. Plus a frippery. Omicron update … Continue reading →
